ConforMIS

ConforMIS, Inc. is a medical technology company, which engages in the development, manufacture, and sale of joint replacement implants. It operates through the following geographical segments: United States, Germany, and Rest of the World. The firm's products include iUni, iDuo, iTotal CR, and iTotal. The company was founded by Philipp Lang in 2004 and is headquartered in Billerica, MA.

Earnings data Q2 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Conformis is a medical technology company that uses its proprietary iFit® Image-to-Implant® technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, which it refers to as personalized, individualized, or sometimes as customized, to fit each patient’s unique anatomy. Conformis offers a broad line of sterile, personalized knee and hip implants and single-use instruments delivered to hospitals and ambulatory surgical centers.

ConforMIS (CFMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ConforMIS (CFMS) Earnings Expected to Grow: Should You Buy?

Acasti Pharma

Harmony Gold Mining Co Ltd

Northern Dynasty Minerals

Which penny stocks are investors watching with August only a week away? The post Best Penny Stocks to Buy in August?

Best Penny Stocks to Buy in August? 4 for Your Watchlist

Aerpio Pharmaceuticals Inc

Ault Global Holdings

Looking For the Best Penny Stocks to Watch in July? Check These 4 Out The post Penny Stocks to Buy Right Now?

Penny Stocks to Buy Right Now? 4 For Your Late July Watchlist

Ideanomics Inc

Which Tech Penny Stocks Are on Your July 2021 Watchlist? The post Best Tech Penny Stocks to Buy in 2021?

Best Tech Penny Stocks to Buy in 2021? 3 to Watch in July

BILLERICA, Mass., July 14, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will present at the Canaccord Genuity 40th Annual Growth Conference.

Conformis, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference

Conformis Settles Wright Medical Litigation Related to Patient-Specific Instruments for Use with Shoulder Implants Conformis Settles Wright Medical Litigation Related to Patient-Specific Instruments for Use with Shoulder Implants

Conformis, Inc. Announces Settlement of Wright Medical Patent Litigation

BILLERICA, Mass., July 01, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the second quarter ended June 30, 2021 after the market closes on August 4, 2021 at approximately 4:00 p.m. Eastern Time.

Conformis, Inc. to Release Second Quarter 2021 Financial Results on August 4, 2021

Elys Game Technology, Corp.

Mind Medicine MindMed

NexGen Energy

Protagenic Therapeutics

Senseonics Holdings

Sesen Bio Inc.

Penny stocks offer a lot of risk balanced by lots of reward. Here are 7 that could surge in price and which have reasonable catalysts behind them.

7 Best Penny Stocks to Buy Now for Potential 10X Gains

New Agreement expands Conformis' global reach and brings patient-specific knee replacement systems to the largest market in the Asia-Pacific region New Agreement expands Conformis' global reach and brings patient-specific knee replacement systems to the largest market in the Asia-Pacific region

Conformis, Inc. Announces Exclusive Distribution Agreement in China

Boxlight

Clearside Biomedical

Uxin Ltd - ADR

In a recent pennystocks.com article, we covered 5 Penny Stocks on Reddit for Your June 2021 Watchlist. This piece is a continuation, as more and more valuable penny stocks continue to come to light. Right now, there are a lot of unique factors at play in the stock market. On one hand, we have the pandemic coming to an end.

Penny Stocks to Watch With AMC Stock Back in Focus

Obalon Therapeutics

Tellurian

Looking for penny stocks to buy on Reddit? Check these 4 out for your watchlist The post 4 Penny Stocks Reddit Traders Are Buying Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Penny Stocks Reddit Traders Are Buying Right Now

BILLERICA, Mass., May 18, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, will present at the Oppenheimer MedTech, Tools & Diagnostics Summit.

Conformis, Inc. to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit

BILLERICA, Mass., May 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will present at the Canaccord Genuity Musculoskeletal Conference.

Conformis, Inc. to Present at the Canaccord Genuity Musculoskeletal Conference

PolarityTE Inc

These penny stocks just released big news; will they be on your watchlist? The post Best Penny Stocks to Buy?

Best Penny Stocks to Buy? 3 With Big News Today

Leveraging Conformis' extensive library of personalized knee design data and patient images, Identity Imprint is designed to match patients' anatomy with an optimal arthroplasty solution while at the same time offering greater efficiency, cost savings, increased intraoperative flexibility, and faster delivery times Leveraging Conformis' extensive library of personalized knee design data and patient images, Identity Imprint is designed to match patients' anatomy with an optimal arthroplasty solution while at the same time offering greater efficiency, cost savings, increased intraoperative flexibility, and faster delivery times

Conformis, Inc. Announces 510(k) Clearance for Identity Imprint™ Knee Replacement System

Conformis, Inc. (CFMS) CEO Mark Augusti on Q1 2021 Results - Earnings Call Transcript

ConforMIS (CFMS) delivered earnings and revenue surprises of -12.50% and -0.29%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

ConforMIS (CFMS) Reports Q1 Loss, Misses Revenue Estimates

Shares of Conformis (NASDAQ:CFMS) fell in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 35.71% year over year to ($0.09), which missed the estimate of ($0.07).

Conformis: Q1 Earnings Insights

BILLERICA, Mass., May 05, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the first quarter ended March 31, 2021.

Conformis Reports First Quarter 2021 Financial Results

Conformis (NASDAQ:CFMS) unveils its next round of earnings this Wednesday, May 05. Here is Benzinga's everything-that-matters guide for the earnings announcement.

Conformis's Earnings: A Preview

Will ConforMIS (CFMS) Report Negative Earnings Next Week? What You Should Know

Jaguar Health

Zomedica

Creating a penny stock watchlist? You should check these 3 out The post Best Penny Stocks to Buy?

Best Penny Stocks to Buy? You Might Want to Add These 3 To Your Watchlist

The stock price of ConforMIS Inc (NASDAQ: CFMS) increased by over 10% pre-market. This is why it happened.

CFMS Stock: Over 10% Increase Pre-Market Explanation

BILLERICA, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it received 510(k) clearance by the U.S. Food and Drug Administration for patient-specific instrumentation (“PSI”) developed by the Company under its License Agreement and Development Agreement with Howmedica Osteonics Corp., a wholly owned subsidiary of Stryker Corporation also known as Stryker Orthopaedics. With the clearance of this PSI system, which is designed for use with Stryker's Triathlon® Total Knee System, the Company has achieved the third of three milestones under the agreements and will receive $11.0 million from Stryker.

Conformis Announces Achievement of Third Milestone Under Development and License Agreements

Integra LifeSciences Holdings

Orthofix International

SeaSpine Holdings

Zimmer Biomet Hlds

Here are five orthopedic device stocks, Integra (IART), Conformis (CFMS), SeaSpine (SPNE), Zimmer Biomet (ZBH), Orthofix (OFIX), which are expected to continue their run over the next few months.

News for ConforMIS Stock (CFMS)